Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Development Of A Predictive Score For Maxillary Osteochimionecrosis After Invasive Oral Surgery In Patients Treated Whith Biphosphonates Or Biotherapies: The PREV-ONM Study

NCT04257721 is registered in ClinicalTrials.gov with Centre Hospitalier Sud Francilien as lead sponsor.

NCT NCT04257721
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04257721 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Development Of A Predictive Score For Maxillary Osteochimionecrosis After Invasive Oral Surgery In Patients Treated Whith Biphosphonates Or Biotherapies: The PREV-ONM Study
Lead sponsor
Centre Hospitalier Sud Francilien
Phase
Observational
Overall status
Terminated
Start date
October 10, 2019
Completion date
April 6, 2022
Enrollment
45 (actual)
Sites
5

Conditions

As the registry lists them; a condition with its own page is linked.

osteonecrosis due to drugs, jaw